Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02255370
PHASE3

Curcumin Associated With Thiopurin in the Prevention of Post-op Recurrence in Crohn Disease

Sponsor: University Hospital, Clermont-Ferrand

View on ClinicalTrials.gov

Summary

Curcumin, the active ingredient of turmeric, has been used for long term in the treatment of inflammatory conditions. Inhibition of NF-κB is postulated as the main mechanism responsible for the anti-inflammatory effect of curcumin Aim : to study the effect of curcumin, 3g per day, as compared to placebo, combined with thiopurines in the prevention of Crohn's disease post-operative recurrence.

Official title: Controlled, Randomized, Double Blind Study, Comparing Curcumin to Thiopurines in the Prevention of Post-op Recurrence in Crohn Disease

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

61

Start Date

2014-12

Completion Date

2018-06

Last Updated

2026-05-20

Healthy Volunteers

No

Conditions

Interventions

DRUG

Curcumin

subjects will be randomized into two arms; they will be given either placebo or curcumin 3g/d per os plus thiopurines during 6 months in a double-blind manner. Rutggerts endoscopic score at 6 months will be the main judgment criteria

Locations (1)

CHU de Clermont-Ferrand

Clermont-Ferrand, France